Compatibility Tests

The methods used in compatibility tests should include those that will demostrate ABO and RhD incompatibility and detect clinically significant unexpected antibodies

DiaClon ABD-Confirmation for Patients

The ID-Card DiaClon ABD-Confirmation for Patients can be used for the ABO/RhD blood group control of patients. Current recommendations for RhD typing suggest that, for transfusion recipients and antenatal patients, anti-D reagents should not detect the DVI phenotype. Individuals possessing the DVI phenotype may produce an anti-D to the missing epitopes after immunization by fetal or transfused RhD positive cells. To ensure that appropriate therapeutic measures are instigated, a DVI patient’s red cells should be assigned RhD negative status. Conversely, donor bloods should be tested with anti-D that does detect DVI and assigned RhD positive status, to avoid the unit being transfused to an RhD negative or partial-D patient.

DiaClon ABD-Confirmation for Donors

DiaClon ABD-Confirmation for Donors is used for the ABO/RhD blood group control of donors. Current recommendations for RhD typing suggest that, for transfusion recipients and antenatal patients, anti-D reagents should not detect the DVI phenotype. Individuals possessing the DVI phenotype may produce an anti-D to the missing epitopes after immunization by fetal or transfused RhD positive cells. To ensure that appropriate therapeutic measures are instigated, a DVI patient’s red cells should be assigned RhD negative status. Conversely, donor bloods should be tested with anti-D that does detect DVI and assigned RhD positive status, to avoid the unit being transfused to an RhD negative or partial-D patient.

ABD-Confirmation

To ensure that appropriate therapeutic measures are instigated, a DVI patient’s red cells should be assigned Rh negative status. Conversely, donor blood should be tested with anti-D that detects DVI, and assigned Rh positive status, to avoid the unit being transfused to an RhD negative or partial-D patient.

For the examination of previous transfusion records for the recipient’s serological history.

The results from the current testing must be compared with the interpretation of the previously determined blood group.

ID-Card (Id-n°: 50041):
•Human
•Configuration: A, B, D/A, B, D

Ordering information

Pkg. size

Profiles or single test

REF

4 x 12

96 profiles

001114

24 x 12

576 profiles

001117

60 x 12

1440 profiles

001116

112 x 12

2688 profiles

001115

LISS/Coombs

The methods used in compatibility tests should include those that will demonstrate ABO and RhD incompatibility and detect clinically significant unexpected antibodies. The LISS/Coombs ID-Card allows major crossmatch test by the Indirect Antihumanglobulin test (IAT), and Autocontrol (IAT test).

DiaClon Complete Crossmatch

The methods used in compatibility tests should include those that will demonstrate ABO and RhD incompatibility and detect clinically significant unexpected antibodies. The ID-Card DiaClon Complete Crossmatch is configured to meet the above requirements in one easy step. It allows for ABD-confirmation of both donor and recipient, major crossmatch test by the Indirect Antihumanglobulin test (IAT), major enzyme crossmatch test, and Autocontrol (IAT test).

Complete Crossmatch

The methods used in compatibility tests should include those that will demonstrate ABO and RhD incompatibility and detect clinically significant, unexpected antibodies. The ID-Card Complete Crossmatch is configured to meet the above requirements in one easy step:
– ABD-confirmation of both donor and recipient
– Major crossmatch test by the Indirect Antihumanglobulin test (IAT)
– Major enzyme crossmatch test
– Autocontrol (IAT test)